BTG3 and systemic lupus erythematosus: The proportion of SLE patients according to their ANA (n = 45/50 ANA-positive; 90%), anti-dsDNA (n = 36/50 anti-dsDNA-positive; 72%), or CRP status is presented in Figure 1A.